ASP
ISEE

Adams Street Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Adams Street Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-154,271
Closed -$870K – 20
2020
Q3 		$870K Sell
154,271
-154,268
-50% -$736K 0.23% 13
2020
Q2 		$1.57M Buy
+308,539
New +$1.29M 0.33% 9

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Adams Street Partners's ISEE Position: Q4 2020 in Review

Adams Street Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2020, closing a stake of 154,271 shares — an estimated $870K sold.

Adams Street Partners first reported a position in ISEE in Q2 2020 and held it in 2 quarters. The position peaked at $1.57M in Q2 2020. 120 funds tracked by Wall St. Rank hold ISEE as of Q4 2020.

  • Adams Street Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Adams Street Partners sold 154,271 IVERIC bio, Inc. Common Stock shares in Q4 2020, an estimated $870K.
  • Adams Street Partners first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Adams Street Partners's IVERIC bio, Inc. Common Stock position peaked at $1.57M in Q2 2020.
  • 120 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2020.

Based on Adams Street Partners's 13F filing for Q4 2020, filed 11 Feb 2021.